M. J. Uprichard

Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints.

Tony Reid, E. Galanis, James L. Abbruzzese et al. · PubMed · 2002 · 310 citations

Medicine, Oncology, Pharmacology +17

Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer

Oday Hamid, Mary Varterasian, Scott Wadler et al. · Journal of Clinical Oncology · 2003 · 144 citations

Medicine, Oncology, Pharmacotherapy +17

Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer

Rob Eager, Charles Cunningham, Neil Senzer et al. · Clinical Oncology · 2009 · 89 citations

Medicine, Oncology, Pharmacology +14

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

Robert M Eager, Casey Cunningham, Neil Senzer et al. · BMC Cancer · 2009 · 79 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase I Trial of PT-100 (PT-100), A Cytokine-Inducing Small Molecule, Following Chemotherapy for Solid Tumor Malignancy

John Nemunaitis, Svetislava J. Vukelja, Donald Richards et al. · Cancer Investigation · 2006 · 31 citations

Pharmacy, Oncology, Pharmacotherapy +15